AUTOANTIBODY FORMATION AFTER BONE-MARROW TRANSPLANTATION - A COMPARISON BETWEEN AUTOLOGOUS AND ALLOGENEIC GRAFTS

被引:21
|
作者
SANMARCO, M
VIALETTES, B
MARANINCHI, D
BERNARD, D
机构
[1] Laboratoire d'Immunologic Facullé de Médecine, 13385, Marseille, Cédex 5
[2] Service de Médecine Interne, Hôpital de la Timone, 13385, Marseille, Cédex 5, 254, Rue St-Pierre
[3] Centre de Greffe de Moelle Osseuse, Institut J, 13277, Marseille, Cédex 9, Paoli-1. Calmettes, Bd de Ste Marguerite
关键词
BONE MARROW TRANSPLANTATION; AUTOANTIBODIES;
D O I
10.3109/08916939108994702
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Various autoantibodies were screened in 11 allogeneic, 14 autologous bone marrow transplanted patients and 11 healthy controls. Except anti-mitochondria antibodies, autoantibodies were found with similar frequencies after allogeneic and autologous transplantation. Moreover, 50% of autoantibodies were already present before transplantation. These results suggest that factors other than allogeneic reaction could be responsible for autoantibody formation after bone marrow transplantation, in particular, pre-graft conditioning treatment and/or viral and bacterial infection. Nevertheless, the number of patients with 2 or more autoantibodies was significantly higher after allogeneic than after autologous grafting (respectively, 82% and 36.7%; P<0.05). Forty percent of allografted but none of autografted patients were still positive at 12 months post graft. So, allogeneic reaction could play a role in intensity of humoral response and its maintenance for a long period. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [31] EXPERIENCES WITH ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN 7 PATIENTS
    URBAN, C
    KAULFERSCH, W
    SLAVC, I
    MAURER, G
    MUTZ, I
    HAJEKROSENMAYR, A
    TEUBL, I
    HOCKER, P
    BLUT, 1984, 49 (03): : 292 - 292
  • [32] PULMONARY BONE-MARROW EMBOLIZATION AFTER UNFILTRATED AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    ALVEGARD, TA
    BERG, NO
    WILLEN, H
    ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1984, 92 (01): : 81 - 82
  • [34] COMPARISON OF PATIENT ENERGY AND PROTEIN-LEVELS IN ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    ZIZZI, L
    CARON, G
    BELANGER, R
    GELINAS, MD
    JOURNAL OF THE CANADIAN DIETETIC ASSOCIATION-REVUE DE L ASSOCIATION CANADIENNE DES DIETETISTES, 1994, 55 (02): : 79 - 84
  • [35] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA WITH MARROW GRAFTS TREATED BY COUNTERFLOW CENTRIFUGATION
    DEWITTE, T
    SCHATTENBERG, A
    PREIJERS, F
    RAYMAKERS, R
    MUUS, P
    WESSELS, J
    BONE MARROW TRANSPLANTATION, 1993, 12 : S2 - S6
  • [36] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) AS TREATMENT FOR EXTRAMEDULLARY RELAPSE AFTER ALLOGENEIC BMT
    MILPIED, N
    HAROUSSEAU, JL
    BOURHIS, JH
    GUIMBRETIERE, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 307 - 307
  • [37] BONE-MARROW PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    GRIBBEN, JG
    NADLER, LM
    LEUKEMIA & LYMPHOMA, 1993, 11 : 141 - 148
  • [38] ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GMUR, J
    THERAPEUTISCHE UMSCHAU, 1988, 45 (02) : 131 - 136
  • [39] ALLOGENEIC BONE-MARROW TRANSPLANTATION
    STORB, R
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 414 - 414
  • [40] ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GERRITSEN, W
    LEUKEMIA RESEARCH, 1986, 10 (01) : 77 - 78